197 related articles for article (PubMed ID: 15657211)
1. Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
O'Meara E; McMurray JJ
Heart; 2005 Feb; 91(2):131-2. PubMed ID: 15657211
[TBL] [Abstract][Full Text] [Related]
2. Can metabolic manipulation reverse myocardial dysfunction?
Cokkinos DV
Eur Heart J; 2001 Dec; 22(23):2138-9. PubMed ID: 11913472
[No Abstract] [Full Text] [Related]
3. Metabolic therapy for heart failure.
Essop MF; Opie LH
Eur Heart J; 2004 Oct; 25(20):1765-8. PubMed ID: 15474689
[No Abstract] [Full Text] [Related]
4. The heart metabolism: pathophysiological aspects in ischaemia and heart failure.
Abozguia K; Shivu GN; Ahmed I; Phan TT; Frenneaux MP
Curr Pharm Des; 2009; 15(8):827-35. PubMed ID: 19275646
[TBL] [Abstract][Full Text] [Related]
5. [Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism].
Lopaschuk GD
Presse Med; 1998 Dec; 27(39):2100-4. PubMed ID: 9893703
[TBL] [Abstract][Full Text] [Related]
6. Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.
Dalal JJ; Mishra S
Indian Heart J; 2017; 69(3):393-401. PubMed ID: 28648439
[TBL] [Abstract][Full Text] [Related]
7. Metabolic modulation as a target for heart failure treatment: current perspective.
Chenniapan S; Manchanda SC
Indian Heart J; 2007; 59(4):370-4. PubMed ID: 19126947
[No Abstract] [Full Text] [Related]
8. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism.
Lopaschuk GD
Am J Cardiol; 1998 Sep; 82(5A):14K-17K. PubMed ID: 9737481
[TBL] [Abstract][Full Text] [Related]
9. Metabolic treatment of myocardial ischaemia.
Ferrari R
Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019
[No Abstract] [Full Text] [Related]
10. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
Labrid C
Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
[TBL] [Abstract][Full Text] [Related]
11. Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography.
Mody FV; Singh BN; Mohiuddin IH; Coyle KB; Buxton DB; Hansen HW; Sumida R; Schelbert HR
Am J Cardiol; 1998 Sep; 82(5A):42K-49K. PubMed ID: 9737485
[TBL] [Abstract][Full Text] [Related]
12. Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.
Stanley WC; Sabbah HN
Heart Fail Rev; 2005 Dec; 10(4):275-9. PubMed ID: 16583175
[No Abstract] [Full Text] [Related]
13. [Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].
Eliseev OM
Ter Arkh; 1996; 68(8):57-63. PubMed ID: 9019836
[No Abstract] [Full Text] [Related]
14. Modulation of myocardial metabolism: an emerging therapeutic principle.
Horowitz JD; Chirkov YY; Kennedy JA; Sverdlov AL
Curr Opin Cardiol; 2010 Jul; 25(4):329-34. PubMed ID: 20535068
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic therapy for heart failure].
Loiacono F; Alberti L; Lauretta L; Puccetti P; Silipigni C; Margonato A; Fragasso G
Recenti Prog Med; 2014; 105(7-8):288-94. PubMed ID: 25072544
[TBL] [Abstract][Full Text] [Related]
16. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
17. Metabolic therapy for the diabetic patients with ischaemic heart disease.
Rosano GM; Vitale C; Volterrani M; Fini M
Coron Artery Dis; 2005 Nov; 16 Suppl 1():S17-21. PubMed ID: 16340399
[TBL] [Abstract][Full Text] [Related]
18. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
Stanley WC; Marzilli M
Fundam Clin Pharmacol; 2003 Apr; 17(2):133-45. PubMed ID: 12667223
[TBL] [Abstract][Full Text] [Related]
19. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Belardinelli R
Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
[TBL] [Abstract][Full Text] [Related]
20. Role of trimetazidine in management of ischemic cardiomyopathy.
Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
